BRAIN Biotech AG
XETRA:BNN
BRAIN Biotech AG
XETRA:BNN
Price:
2.79 EUR
0.36%
Market Closed
Updated:
Apr 25, 2024
BRAIN Biotech AG
Cash from Operating Activities
Last
Value
3-Years CAGR
5-Years CAGR
|
BRAIN Biotech AG
Cash from Operating Activities Peer Comparison
Comparables:
WCH
EVK
1COV
ACT
SY1
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
BRAIN Biotech AG
XETRA:BNN
|
Cash from Operating Activities
-€4.8m
|
CAGR 3-Years
15%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Wacker Chemie AG
XETRA:WCH
|
Cash from Operating Activities
€936.3m
|
CAGR 3-Years
2%
|
CAGR 5-Years
13%
|
CAGR 10-Years
7%
|
|
|
Evonik Industries AG
XETRA:EVK
|
Cash from Operating Activities
€1.6B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
4%
|
|
|
Covestro AG
XETRA:1COV
|
Cash from Operating Activities
€997m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
AlzChem Group AG
XETRA:ACT
|
Cash from Operating Activities
€72.7m
|
CAGR 3-Years
14%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
|
Symrise AG
XETRA:SY1
|
Cash from Operating Activities
€703.7m
|
CAGR 3-Years
4%
|
CAGR 5-Years
10%
|
CAGR 10-Years
12%
|
See Also
What is BRAIN Biotech AG's Cash from Operating Activities?
Cash from Operating Activities
-4.8m
EUR
-4.8m
EUR
Based on the financial report for Dec 31, 2023, BRAIN Biotech AG's Cash from Operating Activities amounts to -4.8m EUR.
What is BRAIN Biotech AG's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-2%
-2%
Over the last year, the Cash from Operating Activities growth was -45%. The average annual Cash from Operating Activities growth rates for BRAIN Biotech AG have been 15% over the past three years , -2% over the past five years .
You don't have any saved screeners yet
